The firms will collaborate on two lead programs and up to five future targets in other diseases, with NanoVation eligible for up to $600 million in payments from Novo Nordisk.
NanoVation Therapeutics, a platform company developing innovative technologies to overcome the barriers of nucleic acid delivery, today announced a multi-year partnership with Novo Nordisk to advance ...
Keywords: Non-canonical Nucleic acids, G-quadruplexes, Expandable repeats, Gene expression, R-loops Important Note: All contributions to this Research Topic must be within the scope of the section and ...
Thanks to a serendipitous discovery and a lot of painstaking work, scientists can now build biohybrid molecules that combine the homing powers of DNA with the broad functional repertoire of proteins - ...
STONY BROOK, NY / / September 17, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ('Applied DNA' or the 'Company'), a leader in PCR-based DNA technologies, today announced it has received a follow-on ...
Understanding protein function within living cells is crucial for basic research and therapeutic development. Protein kinetics in living cells provide more relevant insights compared to studies in ...